Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors-Reference-Cited by-同舟云学术

Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors

Published:2005-07-13 Issue:20 Volume:26 Page:2154-2158
ISSN:1522-9645
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Krum Henry,Haas Steven Joseph,Eichhorn Eric,Ghali Jalal,Gilbert Edward,Lechat Philippe,Packer Milton,Roecker Ellen,Verkenne Patricia,Wedel Hans,Wikstrand John

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/26/20/2154/9624173/ehi409.pdf

Reference14 articles.

1. Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldmanmd AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Gregoratos G, Jacobs AK, Hiratzka LF, Russell RO, Smith SC Jr; American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure); International Society for Heart and Lung Transplantation; Heart Failure Society of America. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Circulation2001;104:2996–3007.

2. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA1995;273:1450–1456.

3. The Beta-Blocker Evaluation of Survival Trial Investigators. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure. N Engl J Med2001;344:1659–1667.

4. CIBIS Investigators and Committees. A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation1994;90:1765–1773.

5. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet1999;353:9–13.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Novel Approach to Medical Management of Heart Failure With Reduced Ejection Fraction;Canadian Journal of Cardiology;2021-04

2. Is Any Patient with Chronic Heart Failure Receiving the Right Dose of the Right Beta-Blocker in Primary Care?;The American Journal of Medicine;2019-11

3. Henry and Mount Rushmore;Journal of Cardiac Failure;2017-09

4. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10‐Year Cohort;Journal of the American Heart Association;2016-01-13

5. Are cardiovascular trial results systematically different between North America and Europe? A study based on intra-meta-analysis comparisons;Archives of Cardiovascular Diseases;2015-01